Compound ID | 367

S-3578

Class: Beta-lactam

Agent Type: Semisynthetic; Small molecule; Direct acting;
Spectrum of activity: Gram-positive
Mechanism of action: Cell wall synthesis inhibitor
Target Pathogen: Active against methicillin-resistant Staphylococcus epidermidis
Description: Parenteral cephalosporin
Institute where first reported: Shionogi
Year first mentioned: 2001
Highest development stage: Phase 1
Development status: Inactive

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.